Back To: Home : Featured Technology : High Throughput Screening

CLICK HERE FOR WHAT'S NEW IN:
 

High-Throughput RNAi Screening
October 2007
SHARING OPTIONS:

Cellectricon, a provider of miniaturized and cell-based screening solutions for drug discovery, recently announced collaboration with EPFL (Icole Polytechnique Fidirale de Lausanne, Switzerland). EPFL is evaluating Cellectricon's next-generation high throughput electroporation system. Cellaxess-HT is the world's first high-throughput electroporation system tailor-made for genome-wide RNAi screening and will be launched Q2 2008. Cellaxess-HT addresses the critical need for high-throughput delivery of genetic materials to hard to transfect cells in several cell-based screening assays. Cellaxess-HT will be the only fully automated system on the market allowing for high-throughput electroporation of cells in culture directly in 384-well microplates. The throughput for the system is up to 50,000 wells per day and allows for genome-wide screening with high transfection efficiencies and viabilities in cell lines as well as primary cell types.
Cellectricon AB
+46 (0)31 760 35 00

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.